Oren Gilad - Net Worth and Insider Trading
Oren Gilad Net Worth
The estimated net worth of Oren Gilad is at least $1 Million dollars as of 2024-11-05. Oren Gilad is the President/CEO of Aprea Therapeutics Inc and owns about 335,195 shares of Aprea Therapeutics Inc (APRE) stock worth over $1 Million. Details can be seen in Oren Gilad's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Oren Gilad has not made any transactions after 2024-10-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Oren Gilad
Oren Gilad Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Oren Gilad owns 1 companies in total, including Aprea Therapeutics Inc (APRE) .
Click here to see the complete history of Oren Gilad’s form 4 insider trades.
Insider Ownership Summary of Oren Gilad
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| APRE | Aprea Therapeutics Inc | 2024-10-15 | President & CEO |
Oren Gilad Latest Holdings Summary
Oren Gilad currently owns a total of 1 stock. Oren Gilad owns 335,195 shares of Aprea Therapeutics Inc (APRE) as of October 23, 2024, with a value of $1 Million.
Latest Holdings of Oren Gilad
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| APRE | Aprea Therapeutics Inc | 2024-10-23 | 335,195 | 3.97 | 1,331,304 |
Holding Weightings of Oren Gilad
Oren Gilad Form 4 Trading Tracker
According to the SEC Form 4 filings, Oren Gilad has made a total of 4 transactions in Aprea Therapeutics Inc (APRE) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Aprea Therapeutics Inc is the acquisition of 500 shares on October 23, 2024, which cost Oren Gilad around $1,960.
Insider Trading History of Oren Gilad
- 1
Oren Gilad Trading Performance
GuruFocus tracks the stock performance after each of Oren Gilad's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Oren Gilad is -23.78%. GuruFocus also compares Oren Gilad's trading performance to market benchmark return within the same time period. The performance of stocks bought by Oren Gilad within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Oren Gilad's insider trading performs compared to the benchmark.
Performance of Oren Gilad
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 2.88 |  | | | | |
| Relative Return to S&P 500(%) | 3.69 | | | | | |
Oren Gilad Ownership Network
Ownership Network List of Oren Gilad
Ownership Network Relation of Oren Gilad
Oren Gilad Owned Company Details
What does Aprea Therapeutics Inc do?
Who are the key executives at Aprea Therapeutics Inc?
Oren Gilad is the President & CEO of Aprea Therapeutics Inc. Other key executives at Aprea Therapeutics Inc include SrVP/CFO/Prin. Fin &Acctg. Off John P. Hamill , director & President & CEO Christian S Schade , and SVP & Chief Medical Officer Eyal C. Attar .
Aprea Therapeutics Inc (APRE) Insider Trades Summary
Over the past 18 months, Oren Gilad made 4 insider transaction in Aprea Therapeutics Inc (APRE) with a net purchase of 3,900. Other recent insider transactions involving Aprea Therapeutics Inc (APRE) include a net purchase of 26,957 shares made by Bernd R. Seizinger , a net purchase of 23,728 shares made by Marc Duey , and a net purchase of 1,510 shares made by John P. Hamill .
In summary, during the past 3 months, insiders sold 6,462 shares of Aprea Therapeutics Inc (APRE) in total and bought 42,590 shares, with a net purchase of 36,128 shares. During the past 18 months, 6,462 shares of Aprea Therapeutics Inc (APRE) were sold and 69,417 shares were bought by its insiders, resulting in a net purchase of 62,955 shares.
Aprea Therapeutics Inc (APRE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aprea Therapeutics Inc Insider Transactions
Oren Gilad Mailing Address
Above is the net worth, insider trading, and ownership report for Oren Gilad. You might contact Oren Gilad via mailing address: 535 Boylston Street, Boston Ma 02116.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
